GOVX
GeoVax Labs, Inc.Company with tickers: GOVX
CIK
832489
CUSIP
373678705
Shares Outstanding
5,210,465
13F Activity (30d)
12 filings
12 filers
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2020-08-25 | NEWMAN MARK J |
Chief Scientific Officer | Other | 0 |
| 2020-09-29 | Kollintzas Dean G |
Director | Buy | 11,987 |
| 2020-09-29 | CHASE RANDAL D |
Director | Buy | 16,613 |
| 2020-09-29 | Reynolds Mark |
CFO | Buy | 60,184 |
| 2020-09-29 | MCNALLY ROBERT T |
Director | Buy | 53,925 |
| 2020-09-29 | DODD DAVID A |
Director, President, CEO | Buy | 81,870 |
| 2020-09-29 | DODD DAVID A |
Director, President, CEO | Buy | 81,870 |
| 2020-09-29 | Kollintzas Dean G |
Director | Buy | 11,987 |
| 2020-09-29 | SPENCER JOHN N JR |
Director | Buy | 21,024 |
| 2020-09-29 | CHASE RANDAL D |
Director | Buy | 16,613 |
| 2020-09-29 | Reynolds Mark |
CFO | Buy | 60,184 |
| 2020-09-29 | SPENCER JOHN N JR |
Director | Buy | 21,024 |
| 2020-09-29 | MCNALLY ROBERT T |
Director | Buy | 53,925 |
| 2021-08-11 | Kollintzas Dean G |
Director | Award | 25,000 |
| 2021-08-11 | DODD DAVID A |
Director, President, CEO | Award | 273,000 |
| 2021-08-11 | SPENCER JOHN N JR |
Director | Award | 25,000 |
| 2021-08-11 | Reynolds Mark |
CFO | Award | 128,000 |
| 2021-08-11 | CHASE RANDAL D |
Director | Award | 25,000 |
| 2021-08-11 | NEWMAN MARK J |
Chief Scientific Officer | Award | 35,000 |
| 2021-08-11 | MCNALLY ROBERT T |
Director | Award | 25,000 |
| 2021-12-07 | CHASE RANDAL D |
Director | Award | 25,000 |
| 2021-12-07 | Kollintzas Dean G |
Director | Award | 25,000 |
| 2021-12-07 | NEWMAN MARK J |
Chief Scientific Officer | Award | 25,700 |
| 2021-12-07 | DODD DAVID A |
Director, President, CEO | Award | 103,000 |
| 2021-12-07 | Reynolds Mark |
CFO | Award | 48,200 |
| 2021-12-07 | SPENCER JOHN N JR |
Director | Award | 25,000 |
| 2021-12-07 | MCNALLY ROBERT T |
Director | Award | 25,000 |
| 2022-01-06 | McKee Kelly T. Jr. |
Chief Medical Officer | Other | 0 |
| 2022-05-04 | McKee Kelly T. Jr. |
Chief Medical Officer | Buy | 4,999 |
| 2022-05-05 | McKee Kelly T. Jr. |
Chief Medical Officer | Buy | 9,722 |
| 2022-06-13 | Sharkey John W. |
VP, Business Development | Other | 0 |
| 2022-06-13 | Sharkey John W. |
VP, Business Development | Other | 1,860 |
| 2022-06-21 | CHASE RANDAL D |
Director | Buy | 10,000 |
| 2022-06-27 | McKee Kelly T. Jr. |
Chief Medical Officer | Buy | 4,464 |
| 2022-07-01 | Sharkey John W. |
VP, Business Development | Buy | 1,000 |
| 2022-08-31 | Lemerond Nicole |
Director | Other | 0 |
| 2022-09-21 | CHASE RANDAL D |
Director | Buy | 10,000 |
| 2022-12-07 | Morgan Jayne |
Director | Other | 0 |
| 2023-04-20 | Reynolds Mark |
CFO | Buy | 8,000 |
| 2023-04-24 | DODD DAVID A |
Director, President, CEO | Buy | 32,000 |
| 2023-08-01 | SPENCER JOHN N JR |
Director | Award | 50,000 |
| 2023-08-01 | McKee Kelly T. Jr. |
Chief Medical Officer | Award | 15,000 |
| 2023-08-01 | Morgan Jayne |
Director | Award | 50,000 |
| 2023-08-01 | Lemerond Nicole |
Director | Award | 50,000 |
| 2023-08-01 | NEWMAN MARK J |
Chief Scientific Officer | Award | 100,000 |
| 2023-08-01 | MCNALLY ROBERT T |
Director | Award | 50,000 |
| 2023-08-01 | Reynolds Mark |
CFO | Award | 100,000 |
| 2023-08-01 | Sharkey John W. |
VP, Business Development | Award | 100,000 |
| 2023-08-01 | CHASE RANDAL D |
Director | Award | 50,000 |
| 2023-08-01 | Kollintzas Dean G |
Director | Award | 50,000 |
Showing 1–50 of 87 transactions